Unprecedented OS with the addition of tarlatamab to first-line maintenance therapy for ES-SCLC
Source Nature 医学研究17h ago
Summary
We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.
Open original- Desk
- Health
- Region
- Global
- Language
- English
- Item ID
- health-44642a74
Comments 0 comments
No comments yet. Be the first.